Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Dalbavancin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 128,762Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fresenius Kabi Launches Single-Dose Dalbavancin Injection
    Fresenius Kabi Launches Single-Dose Dalbavancin Injection

    24 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251124982440/en/Fresenius-Kabi-Introduces-Dalbavancin-for-Injection-for-single-dose-regimen-use-only

    BUSINESSWIRE
    24 Nov 2025
    Share Share
    Freseni Kabi’s Generics Dalbavancin HCl Receives Approval in US
    Freseni Kabi’s Generics Dalbavancin HCl Receives Approval in US

    10 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217591

    FDA
    10 Nov 2025
    Share Share
    Teva’s Generics Dalbavancin Hydrochloride Receives Approval in US
    Teva’s Generics Dalbavancin Hydrochloride Receives Approval in US

    23 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219465

    FDA
    23 Oct 2025
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Dalbavancin Hydrochloride
    FDA Confirms Paragraph IV Patent Litigation for Dalbavancin Hydrochloride

    08 Aug 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-dalbavancin-hydrochloride-98816.pdf

    FDA
    08 Aug 2023
    Share Share
    Paladin Labs Launches of Xydalba (dalbavancin for injection) in Canada
    Paladin Labs Launches of Xydalba (dalbavancin for injection) in Canada

    18 Jan 2022

    // YAHOO FINANCE

    https://finance.yahoo.com/news/paladin-labs-announces-launch-xydalba-123000837.html

    YAHOO FINANCE
    18 Jan 2022
    Share Share
    Trial of existing antibiotic for treating Staphylococcus aureus bacteremia
    Trial of existing antibiotic for treating Staphylococcus aureus bacteremia

    27 Apr 2021

    // NIH

    https://www.nih.gov/news-events/news-releases/trial-existing-antibiotic-treating-staphylococcus-aureus-bacteremia-begins

    NIH
    27 Apr 2021
    Share Share